PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies.
Saved in:
| Title: | PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies. |
|---|---|
| Authors: | Garside J; Janssen EMEA HEMAR, High Wycombe, UK., Healy N; Janssen-Cilag EMEA Medical Affairs, Dublin, Ireland., Besson H; Janssen EU HEMAR Statistics & Modelling, Beerse, Belgium., Hermans R; QuintilesIMS RWE Solutions, London, UK., MacDougall F; QuintilesIMS RWE Solutions, London, UK., Lestelle D; QuintilesIMS RWE Solutions, London, UK., Diels J; Janssen EU HEMAR Statistics & Modelling, Beerse, Belgium., Iraqi W; Janssen Pharmaceuticals, Paris, France. |
| Source: | Journal of comparative effectiveness research [J Comp Eff Res] 2018 Jan; Vol. 7 (1), pp. 29-38. Date of Electronic Publication: 2017 Aug 02. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Becaris Publishing Country of Publication: England NLM ID: 101577308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6313 (Electronic) Linking ISSN: 20426305 NLM ISO Abbreviation: J Comp Eff Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2042-6313 |
|---|---|
| DOI: | 10.2217/cer-2017-0046 |
